statistiche ricercatore

Continente	#
NA - Nord America	764
AS - Asia	330
EU - Europa	314
SA - Sud America	66
Continente sconosciuto - Info sul continente non disponibili	32
AF - Africa	10
OC - Oceania	7
Totale	1.523

Nazione	#
US - Stati Uniti d'America	747
SG - Singapore	138
IT - Italia	79
CN - Cina	72
RU - Federazione Russa	65
VN - Vietnam	56
BR - Brasile	50
DE - Germania	30
FI - Finlandia	25
GB - Regno Unito	19
FR - Francia	18
SE - Svezia	12
CA - Canada	10
HK - Hong Kong	10
ID - Indonesia	10
LV - Lettonia	10
IN - India	9
NL - Olanda	9
AT - Austria	8
KR - Corea	8
AU - Australia	7
ES - Italia	7
ZA - Sudafrica	7
AR - Argentina	6
CZ - Repubblica Ceca	6
IQ - Iraq	6
PL - Polonia	6
BD - Bangladesh	5
CH - Svizzera	5
MX - Messico	5
EC - Ecuador	4
IL - Israele	4
UA - Ucraina	4
AE - Emirati Arabi Uniti	2
BG - Bulgaria	2
CL - Cile	2
CO - Colombia	2
JP - Giappone	2
KE - Kenya	2
LT - Lituania	2
RO - Romania	2
SK - Slovacchia (Repubblica Slovacca)	2
BE - Belgio	1
DZ - Algeria	1
HN - Honduras	1
IR - Iran	1
JO - Giordania	1
KG - Kirghizistan	1
KZ - Kazakistan	1
MD - Moldavia	1
NI - Nicaragua	1
OM - Oman	1
PE - Perù	1
PK - Pakistan	1
PY - Paraguay	1
RS - Serbia	1
TH - Thailandia	1
TR - Turchia	1
Totale	1.491

Nome	#
Vaccination with a FAT1-derived B cell epitope combined with tumor-specific B and T cell epitopes elicits additive protection in cancer mouse models	234
Synergistic protective activity of tumor-specific epitopes engineered in bacterial outer membrane vesicles	199
Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine	196
Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli	181
Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform	166
Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines	127
Outer membrane vesicles from the gut microbiome contribute to tumor immunity by eliciting cross-reactive T cells	123
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine	109
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles	101
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells	87
Totale	1.523

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	77	0	5	0	4	7	6	2	9	11	9	6	18
2022/2023	110	18	10	8	19	4	14	2	9	10	1	6	9
2023/2024	70	1	3	3	2	3	21	0	7	2	10	2	16
2024/2025	311	7	1	31	65	10	35	4	19	12	65	24	38
2025/2026	668	66	28	71	115	68	48	105	17	57	50	23	20
2026/2027	33	10	23	0	0	0	0	0	0	0	0	0	0
Totale													1.523